Aspire BioPharma Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

0.34

-0.02 (-5.29%)

At close: May 02, 2025, 3:59 PM

0.38

11.59%

After-hours: May 02, 2025, 05:56 PM EDT

Aspire BioPharma Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Net Income	-9.44M	-581.21K	-403.12K	-396.46K	-232.59K	-155.81K	-90.27K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	1.06M	255.95K	309.35K	355.13K	291.11K	-126.98K	109.79K
Other Non-Cash Items	8.11M	-78.19K	-78.19K	-1.12K	4.5K	4.5K	4.5K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1.06M	255.95K	309.35K	355.13K	291.11K	-126.98K	109.79K
Operating Cash Flow	-265.19K	-403.45K	-171.96K	-42.46K	63.02K	-278.28K	24.02K
Capital Expenditures	-18.82K	-37.64K	-37.64K	-37.64K	-37.64K	-18.82K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	18.82K	-38.26K	-38.26K	-38.26K	-19.13K	37.95K	-19.13K
Investing Cash Flow	n/a	-75.9K	-75.9K	-75.9K	-56.77K	19.13K	-19.13K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	257.65K	481.3K	257.65K	128.82K	n/a	268.82K	n/a
Financial Cash Flow	257.65K	481.3K	257.65K	128.82K	n/a	268.82K	n/a
Net Cash Flow	-27.14K	-17.66K	-9.82K	-9.82K	1.36K	4.78K	n/a
Free Cash Flow	-226.93K	-441.1K	-209.6K	-80.1K	25.38K	-240.03K	24.02K